Back to Search
Start Over
Moderator's view: The use of calcineurin inhibitors in the treatment of lupus nephritis
- Source :
- Nephrology Dialysis Transplantation. 31:1572-1576
- Publication Year :
- 2016
- Publisher :
- Oxford University Press (OUP), 2016.
-
Abstract
- Lupus nephritis (LN) is one of the most severe manifestations of systemic lupus erythematosus (SLE), affecting ∼50% of patients, and both renal disease and treatment-related toxicity contribute to significant morbidity and mortality. Although our understanding of the aetiopathogenesis of LN is improving, treatment still remains a challenge, with the achievement of complete remission at 1 year in
- Subjects :
- 030203 arthritis & rheumatology
Oncology
Transplantation
medicine.medical_specialty
Proteinuria
Cyclophosphamide
business.industry
030232 urology & nephrology
Lupus nephritis
Renal function
medicine.disease
Organ transplantation
Tacrolimus
Calcineurin
03 medical and health sciences
0302 clinical medicine
Nephrology
Cyclosporin a
Internal medicine
Immunology
medicine
medicine.symptom
business
medicine.drug
Subjects
Details
- ISSN :
- 14602385 and 09310509
- Volume :
- 31
- Database :
- OpenAIRE
- Journal :
- Nephrology Dialysis Transplantation
- Accession number :
- edsair.doi...........18480b32fa479df3075ee0941ed0c44f